OpenEvidence, the fast-growing startup behind an AI assistant that helps physicians find and summarize medical information, has fielded investor offers to raise roughly $200 million at a valuation of about $20 billion — a figure that would nearly double its most recent price tag from earlier this year.
"ChatGPT for Doctors" · Health-AI Funding
OpenEvidence Eyes a $20 Billion Valuation — Nearly Double January's Price
The medical-AI startup has fielded investor offers to raise roughly $200 million at about a $20 billion valuation — the latest step in an extraordinary run of escalating rounds. The figure reflects offers under consideration, not a closed deal.
$20B
Reported target valuation (offers under consideration)
40%+
of U.S. physicians said to log in for clinical decisions
200M+
AI-powered clinical consultations supported
A valuation that keeps resetting upward
From $1B to a reported $20B in roughly one year — column height is proportional to valuation.
Adoption & footprint
Used across 10,000+ U.S. hospitals & medical centers
Tens of thousands of new clinician sign-ups each month
Official AI partner of the New England Journal of Medicine
4.9/5 across 11,000+ App Store reviews
Est. revenue ~$150M /yr, mainly from pharma advertising
Open questions & limits
44% of polled doctors cite accuracy / misinformation risk
16% flag legal-liability concerns; explainability gaps
Reduced accuracy on complex, multi-select subspecialty questions
An advertising-driven model some analysts question
Restricted to U.S. clinicians — kept out of EU & UK
A $20 billion raise, if completed, would crystallize the market's aggressive bet on AI in medicine.
Even as questions about accuracy, liability and the durability of an advertising-driven business model remain unresolved — with final clinical judgment still resting on the physician.
Continue reading The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in ✓ Signed in — this article isn’t included in your current plan.Unlocking the full article…